Fortress Biotech, Inc. Quarterly Debt-to-equity in % from Q2 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Fortress Biotech, Inc. quarterly Debt-to-equity history and growth rate from Q2 2012 to Q3 2024.
  • Fortress Biotech, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 750 %, a 1.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 750 +10.4 +1.4% Sep 30, 2024
Q2 2024 822 +254 +44.8% Jun 30, 2024
Q1 2024 861 +436 +103% Mar 31, 2024
Q4 2023 806 +484 +150% Dec 31, 2023
Q3 2023 740 +501 +210% Sep 30, 2023
Q2 2023 568 +356 +168% Jun 30, 2023
Q1 2023 424 +240 +130% Mar 31, 2023
Q4 2022 322 +158 +96.1% Dec 31, 2022
Q3 2022 238 +79.1 +49.7% Sep 30, 2022
Q2 2022 212 +72.5 +52.1% Jun 30, 2022
Q1 2022 184 +31.7 +20.8% Mar 31, 2022
Q4 2021 164 -25.9 -13.6% Dec 31, 2021
Q3 2021 159 -103 -39.2% Sep 30, 2021
Q2 2021 139 -265 -65.6% Jun 30, 2021
Q1 2021 152 -336 -68.8% Mar 31, 2021
Q4 2020 190 -371 -66.1% Dec 31, 2020
Q3 2020 262 -429 -62.1% Sep 30, 2020
Q2 2020 405 -190 -32% Jun 30, 2020
Q1 2020 488 -40.5 -7.66% Mar 31, 2020
Q4 2019 561 +114 +25.6% Dec 31, 2019
Q3 2019 691 +370 +116% Sep 30, 2019
Q2 2019 594 +282 +90.2% Jun 30, 2019
Q1 2019 529 +280 +113% Mar 31, 2019
Q4 2018 447 +240 +116% Dec 31, 2018
Q3 2018 321 +118 +58% Sep 30, 2018
Q2 2018 313 +137 +77.8% Jun 30, 2018
Q1 2018 249 +69.4 +38.7% Mar 31, 2018
Q4 2017 207 +57.4 +38.3% Dec 31, 2017
Q3 2017 203 +99.7 +96.7% Sep 30, 2017
Q2 2017 176 +102 +139% Jun 30, 2017
Q1 2017 179 +118 +194% Mar 31, 2017
Q4 2016 150 +94.6 +171% Dec 31, 2016
Q3 2016 103 +57.5 +126% Sep 30, 2016
Q2 2016 73.6 +36 +95.6% Jun 30, 2016
Q1 2016 61.1 +29.4 +92.6% Mar 31, 2016
Q4 2015 55.2 +29 +110% Dec 31, 2015
Q3 2015 45.6 +20.1 +79.1% Sep 30, 2015
Q2 2015 37.6 +13.4 +55.2% Jun 30, 2015
Q1 2015 31.7 +4.88 +18.2% Mar 31, 2015
Q4 2014 26.2 -5.66 -17.7% Dec 31, 2014
Q3 2014 25.5 -16.5 -39.3% Sep 30, 2014
Q2 2014 24.3 -36.5 -60.1% Jun 30, 2014
Q1 2014 26.8 -28.1 -51.2% Mar 31, 2014
Q4 2013 31.9 -16.1 -33.5% Dec 31, 2013
Q3 2013 41.9 +7.94 +23.4% Sep 30, 2013
Q2 2013 60.8 -21.7 -26.3% Jun 30, 2013
Q1 2013 54.9 Mar 31, 2013
Q4 2012 47.9 Dec 31, 2012
Q3 2012 34 Sep 30, 2012
Q2 2012 82.5 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.